Literature DB >> 15066327

Fluorescence in situ hybridization analysis of allelic losses involving the long arm of chromosome 17 in NF1-associated neurofibromas.

Alessandro De Luca1, Laura Bernardini, Caterina Ceccarini, Lorenzo Sinibaldi, Antonio Novelli, Sandra Giustini, Innocenzi Daniele, Stefano Calvieri, Rita Mingarelli.   

Abstract

Neurofibromatosis type 1 (NF1) is a common autosomal dominant condition associated with germline mutations of the NF1 gene located at chromosome band 17q11.2. Molecular analysis of a number of NF1-specific tumors has shown the inactivation of both NF1 alleles during tumorigenesis, supporting the tumor suppressor hypothesis for the NF1 gene. Using interphase dual-color fluorescence in situ hybridization (FISH) technique on paraffin-embedded tissues, we studied 11 plexiform, 4 cutaneous, and 6 subcutaneous neurofibromas. Cytogenetic analysis was conducted using two probes, one specific for the NF1 region (RP11-229K15) and one for the centromeric region of chromosome 17 as control. No large somatic deletions were found. Only in one of the plexiform neurofibromas loss of a whole chromosome 17 was observed. If we assume that dual-color FISH analysis is sensitive enough to detect the majority of large somatic deletions present, then other mutational mechanisms affecting the NF1 gene are probably involved in neurofibroma formation, and other tumor suppressor genes may play an important role in NF1 tumorigenesis.

Entities:  

Mesh:

Year:  2004        PMID: 15066327     DOI: 10.1016/j.cancergencyto.2003.09.001

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.

Authors:  A De Luca; I Bottillo; M C Dasdia; A Morella; V Lanari; L Bernardini; L Divona; S Giustini; L Sinibaldi; A Novelli; I Torrente; A Schirinzi; B Dallapiccola
Journal:  J Med Genet       Date:  2007-12       Impact factor: 6.318

2.  The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing.

Authors:  Fan Yang; Song Xu; Renwang Liu; Tao Shi; Xiongfei Li; Xuebing Li; Gang Chen; Hongyu Liu; Qinghua Zhou; Jun Chen
Journal:  Onco Targets Ther       Date:  2018-02-21       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.